Skip to main content

Advertisement

Log in

Bacterial vaginosis and host immunity

  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

Abstract

Bacterial vaginosis (BV) has been associated with severe medical consequences including induction of preterm birth and increasing susceptibility to infection by HIV and other genital tract pathogens. Although the mechanism by which BV induces these changes is not yet fully defined, the presence of BV is accompanied by immunologic changes in the lower genital tract environment. The most striking change is the induction of higher levels of proinflammatory cytokines, although this is not accompanied by increased levels of neutrophils. Increased cytokine levels are likely induced by bacterial products present in BV through innate immune recognition pathways such as the toll-like receptors. Recent studies show that changes in HIV susceptibility and HIV detection are associated with changes in bacterial flora. Further research is needed to identify the relative contributions of immune pathways and bacterial flora toward the pathogenic alterations that occur in BV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Schwebke JR: Gynecologic consequences of bacterial vaginosis. Obstet Gynecol Clin North Am 2003, 30:685–694.

    Article  PubMed  Google Scholar 

  2. Greenblatt RM, Bacchetti P, Barkan S, et al.: Lower genital tract infections among HIV-infected and high-risk uninfected women: findings of the Women’s Interagency HIV Study (WIHS). Sex Transm Dis 1999, 26:143–151.

    Article  PubMed  CAS  Google Scholar 

  3. Sewankambo N, Gray RH, Wawer MJ, et al.: HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis [see comments]. Lancet 1997, 350:546–550. [Published erratum appears in Lancet 1997, 350:1036.]

    Article  PubMed  CAS  Google Scholar 

  4. Taha TE, Gray RH, Kumwenda NI, et al.: HIV infection and disturbances of vaginal flora during pregnancy. J Acquir Immune Defic Syndr Hum Retrovirol 1999, 20:52–59.

    PubMed  CAS  Google Scholar 

  5. Thorsen P, Vogel I, Molsted K, et al.: Risk factors for bacterial vaginosis in pregnancy: a population-based study on Danish women. Acta Obstet Gynecol Scand 2006, 85:906–911.

    Article  PubMed  Google Scholar 

  6. Martin HL, Richardson BA, Nyange PM, et al.: Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999, 180:1863–1868.

    Article  PubMed  CAS  Google Scholar 

  7. Ness RB, Hillier SL, Richter HE, et al.: Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol 2002, 100:765.

    Article  PubMed  Google Scholar 

  8. Forsum U, Holst E, Larsson PG, et al.: Bacterial vaginosis—a microbiological and immunological enigma. Apmis 2005, 113:81–90.

    Article  PubMed  CAS  Google Scholar 

  9. Hill GB: The microbiology of bacterial vaginosis. Am J Obstet Gynecol 1993, 169:450–454.

    PubMed  CAS  Google Scholar 

  10. Fredricks DN, Fiedler TL, Marrazzo JM: Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005, 353:1899–1911.

    Article  PubMed  CAS  Google Scholar 

  11. Antonio MA, Hawes SE, Hillier SL: The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis 1999, 180:1950–1956.

    Article  PubMed  CAS  Google Scholar 

  12. Eschenbach DA, Davick PR, Williams BL, et al.: Prevalence of hydrogen peroxide—producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989, 27:251–256.

    PubMed  CAS  Google Scholar 

  13. Hawes SE, Hillier SL, Benedetti J, et al.: Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996, 174:1058–1063.

    PubMed  CAS  Google Scholar 

  14. Amsel R, Totten PA, Spiegel CA, et al.: Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983, 74:14–22.

    Article  PubMed  CAS  Google Scholar 

  15. Nugent RP, Krohn MA, Hillier SL: Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991, 29:297–301.

    PubMed  CAS  Google Scholar 

  16. Hillier SL, Nugent RP, Eschenbach DA, et al.: Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group [see comments]. N Engl J Med 1995, 333:1737–1742.

    Article  PubMed  CAS  Google Scholar 

  17. McGregor JA, French JI, Parker R, et al.: Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 1995, 173:157–167.

    Article  PubMed  CAS  Google Scholar 

  18. Hauth JC, Goldenberg RL, Andrews WW, et al.: Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis [see comments]. N Engl J Med 1995, 333:1732–1736.

    Article  PubMed  CAS  Google Scholar 

  19. Hillier SL, Kiviat NB, Hawes SE, et al.: Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol 1996, 175:435–441.

    Article  PubMed  CAS  Google Scholar 

  20. Ralph SG, Rutherford AJ, Wilson JD: Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study. BMJ 1999, 319:220–223.

    PubMed  CAS  Google Scholar 

  21. Cohen CR, Duerr A, Pruithithada N, et al.: Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 1995, 9:1093–1097.

    Article  PubMed  CAS  Google Scholar 

  22. Taha TE, Hoover DR, Dallabetta GA, et al.: Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998, 12:1699–1706.

    Article  PubMed  CAS  Google Scholar 

  23. Cherpes TL, Meyn LA, Krohn MA, et al.: Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003, 37:319–325.

    Article  PubMed  Google Scholar 

  24. Mattsby-Baltzer I, Platz-Christensen JJ, Hosseini N, Rosen P: IL-1beta, IL-6, TNFalpha, fetal fibronectin, and endotoxin in the lower genital tract of pregnant women with bacterial vaginosis. Acta Obstet Gynecol Scand 1998, 77:701–706.

    Article  PubMed  CAS  Google Scholar 

  25. Platz-Christensen JJ, Mattsby-Baltzer I, Thomsen P, Wiqvist N: Endotoxin and interleukin-1 alpha in the cervical mucus and vaginal fluid of pregnant women with bacterial vaginosis. Am J Obstet Gynecol 1993, 169:1161–1166.

    PubMed  CAS  Google Scholar 

  26. Hayashi F, Means TK, Luster AD: Toll-like receptors stimulate human neutrophil function. Blood 2003, 102:2660–2669.

    Article  PubMed  CAS  Google Scholar 

  27. Pioli PA, Amiel E, Schaefer TM, et al.: Differential expression of toll-like receptors 2 and 4 in tissues of the human female reproductive tract. Infect Immun 2004, 72:5799–5806.

    Article  PubMed  CAS  Google Scholar 

  28. Fichorova RN, Cronin AO, Lien E, et al.: Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J Immunol 2002, 168:2424–2432.

    PubMed  CAS  Google Scholar 

  29. Al-Harthi L, Spear GT, Hashemi FB, et al.: A human immunodeficiency virus (HIV)-inducing factor from the female genital tract activates HIV-1 gene expression through the kappaB enhancer. J Infect Dis 1998, 178:1343–1351.

    Article  PubMed  CAS  Google Scholar 

  30. Arbour NC, Lorenz E, Schutte BC, et al.: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000, 25:187–191.

    Article  PubMed  CAS  Google Scholar 

  31. Genc MR, Vardhana S, Delaney ML, et al.: Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol 2004, 116:152–156.

    Article  PubMed  CAS  Google Scholar 

  32. Goepfert AR, Varner M, Ward K, et al.: Differences in inflammatory cytokine and toll-like receptor genes and bacterial vaginosis in pregnancy. Am J Obstet Gynecol 2005, 193:1478–1485.

    Article  PubMed  CAS  Google Scholar 

  33. Zariffard MR, Novak RM, Lurain N, et al.: Induction of tumor necrosis factor-alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis. J Infect Dis 2005, 191:1913–1921.

    Article  PubMed  CAS  Google Scholar 

  34. Hillier SL: The vaginal microbial ecosystem and resistance to HIV. AIDS Res Hum Retroviruses 1998, 14(Suppl 1):S17–21.

    PubMed  Google Scholar 

  35. Rotstein OD, Pruett TL, Fiegel VD, et al.: Succinic acid, a metabolic by-product of Bacteroides species, inhibits polymorphonuclear leukocyte function. Infect Immun 1985, 48:402–408.

    PubMed  CAS  Google Scholar 

  36. Wiggins R, Hicks SJ, Soothill PW, et al.: Mucinases and sialidases: their role in the pathogenesis of sexually transmitted infections in the female genital tract. Sex Transm Infect 2001, 77:402–408.

    Article  PubMed  CAS  Google Scholar 

  37. Robertson JA, Stemler ME, Stemke GW: Immunoglobulin A protease activity of Ureaplasma urealyticum. J Clin Microbiol 1984, 19:255–258.

    PubMed  CAS  Google Scholar 

  38. Cauci S, Driussi S, Guaschino S, et al.: Correlation of local interleukin-1beta levels with specific IgA response against Gardnerella vaginalis cytolysin in women with bacterial vaginosis. Am J Reprod Immunol 2002, 47:257–264.

    Article  PubMed  Google Scholar 

  39. Basso B, Gimenez F, Lopez C: IL-1beta, IL-6 and IL-8 levels in gyneco-obstetric infections. Infect Dis Obstet Gynecol 2005, 13:207–211.

    PubMed  CAS  Google Scholar 

  40. Hedges SR, Barrientes F, Desmond RA, Schwebke JR: Local and systemic cytokine levels in relation to changes in vaginal flora. J Infect Dis 2006, 193:556–562.

    Article  PubMed  CAS  Google Scholar 

  41. Genc MR, Karasahin E, Onderdonk AB, et al.: Association between vaginal 70-kd heat shock protein, interleukin-1 receptor antagonist, and microbial flora in mid trimester pregnant women. Am J Obstet Gynecol 2005, 192:916–921.

    Article  PubMed  CAS  Google Scholar 

  42. Alvarez-Olmos MI, Barousse MM, Rajan L, et al.: Vaginal lactobacilli in adolescents: presence and relationship to local and systemic immunity, and to bacterial vaginosis. Sex Transm Dis 2004, 31:393–400.

    Article  PubMed  Google Scholar 

  43. Imseis HM, Greig PC, Livengood CH 3rd, et al.: Characterization of the inflammatory cytokines in the vagina during pregnancy and labor and with bacterial vaginosis. J Soc Gynecol Investig 1997, 4:90–94.

    Article  PubMed  CAS  Google Scholar 

  44. Cauci S, Guaschino S, De Aloysio D, et al.: Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod 2003, 9:53–58.

    Article  PubMed  CAS  Google Scholar 

  45. Sturm-Ramirez K, Gaye-Diallo A, Eisen G, et al.: High levels of tumor necrosis factor-alpha and interleukin-1beta in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. J Infect Dis 2000, 182:467–473.

    Article  PubMed  CAS  Google Scholar 

  46. Spandorfer SD, Neuer A, Giraldo PC, et al.: Relationship of abnormal vaginal flora, proinflammatory cytokines and idiopathic infertility in women undergoing IVF. J Reprod Med 2001, 46:806–810.

    PubMed  CAS  Google Scholar 

  47. Yudin MH, Landers DV, Meyn L, Hillier SL: Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial. Obstet Gynecol 2003, 102:527–534.

    Article  PubMed  CAS  Google Scholar 

  48. Wennerholm UB, Holm B, Mattsby-Baltzer I, et al.: Interleukin-1alpha, interleukin-6 and interleukin-8 in cervico/vaginal secretion for screening of preterm birth in twin gestation. Acta Obstet Gynecol Scand 1998, 77:508–514.

    Article  PubMed  CAS  Google Scholar 

  49. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095–2147.

    PubMed  CAS  Google Scholar 

  50. Diaz-Cueto L, Cuica-Flores A, Ziga-Cordero F, et al.: Genetic variation in the interleukin-8 gene promoter and vaginal concentrations of interleukin-8 are not associated with bacterial vaginosis during pregnancy. J Reprod Immunol 2005, 66:151–160.

    Article  PubMed  CAS  Google Scholar 

  51. Cohen CR, Plummer FA, Mugo N, et al.: Increased interleukin-10 in the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission? AIDS 1999, 13:327–332.

    Article  PubMed  CAS  Google Scholar 

  52. Rein MF, Shih LM, Miller JR, Guerrant RL: Use of a lactoferrin assay in the differential diagnosis of female genital tract infections and implications for the pathophysiology of bacterial vaginosis. Sex Transm Dis 1996, 23:517–521.

    Article  PubMed  CAS  Google Scholar 

  53. Balu RB, Savitz DA, Ananth CV, et al.: Bacterial vaginosis and vaginal fluid defensins during pregnancy. Am J Obstet Gynecol 2002, 187:1267–1271.

    Article  PubMed  CAS  Google Scholar 

  54. Wiesenfeld HC, Heine RP, Krohn MA, et al.: Association between elevated neutrophil defensin levels and endometritis. J Infect Dis 2002, 186:792–797.

    Article  PubMed  CAS  Google Scholar 

  55. Yudin MH, Hillier SL, Wiesenfeld HC, et al.: Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. Am J Obstet Gynecol 2003, 188:318–323.

    Article  PubMed  Google Scholar 

  56. LeBlanc DM, Barousse MM, Field PL Jr: Role for dendritic cells in immunoregulation during experimental vaginal candidiasis. Infect Immun 2006, 74:3213–3221.

    Article  PubMed  CAS  Google Scholar 

  57. Hu J, Gardner MB, Miller CJ: Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol 2000, 74:6087–6095.

    Article  PubMed  CAS  Google Scholar 

  58. Bafica A, Scanga CA, Schito M, et al.: Influence of coinfecting pathogens on HIV expression: evidence for a role of toll-like receptors. J Immunol 2004, 172:7229–7234.

    PubMed  CAS  Google Scholar 

  59. Al-Harthi L, Roebuck KA: Human immunodeficiency virus type-1 transcription: role of the 5′-untranslated leader region [review]. Int J Mol Med 1998, 1:875–881.

    PubMed  CAS  Google Scholar 

  60. Sha BE, Zariffard MR, Wang QJ, et al.: Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis 2005, 191:25–32.

    Article  PubMed  Google Scholar 

  61. Cu-Uvin S, Hogan JW, Caliendo AM, et al.: Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 2001, 33:894–896.

    Article  PubMed  CAS  Google Scholar 

  62. Cohn JA, Hashemi FB, Camarca M, et al.: HIV-inducing factor in cervicovaginal secretions is associated with bacterial vaginosis in HIV-1-infected women. J Acquir Immune Defic Syndr 2005, 39:340–346.

    Article  PubMed  Google Scholar 

  63. Jamieson DJ, Duerr A, Klein RS, et al.: Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study. Obstet Gynecol 2001, 98:656–663.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gregory T. Spear PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

St. John, E., Mares, D. & Spear, G.T. Bacterial vaginosis and host immunity. Curr HIV/AIDS Rep 4, 22–28 (2007). https://doi.org/10.1007/s11904-007-0004-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-007-0004-y

Keywords

Navigation